fasmatech

Fasmatech is proud to announce that Mass Matters, the official publication of the British Mass Spectrometry Society, devotes part of its 50 year Anniversary Edition centerfold to Fasmatech’s R&D Director Dr. Dimitris Papanastasiou, winner of the 2014 Curt Brunnée award for his contribution to the development of the theoretical understanding of ion behaviour and the implementation of his approaches in new devices for ion optics and ion mobility.

Congratulations to  Fasmatech’s co-founder and CSO Dr. Dimitris Papanastasiou for winning the IMSC 2014 Curt Brunnée award.  Dr. Papanastasiou had been nominated by the Hellenic Mass Spectrometry Society for his contributions to the development of the theoretical understanding of ion behaviours and implementation of this knowledge in new devices for ion optics and ion mobility. Dr Papanastasiou will receive the award in a special ceremony during the 20th International Mass Spectrometry Conference in Geneva on […]

June 2014.

Fasmatech’s CEO, Dr. Emmanuel Raptakis and CSO Dr. Dimitris Papanastasiou took part at the ASMS annual conference, which was held from the 15th to the 19th of June 2014 at the Baltimore Convention Center in Baltimore, Maryland. The conference was attended by 6,500 scientists covering the broadest possible spectrum of ion analysis instrumentation and applications. Amongst the highlights of the conference was an excellent tutorial lecture on imaging mass […]

November 2013

Endeavor Greece, the local affiliate of Endeavor Global, has included Fasmatech in their recent report as a prime example of high impact entrepreneurship in the high technology business sector. Their report was presented at an event that attracted a great number of senior figures of Greek business leadership.

Endeavor is leading the global movement to catalyze long-term economic growth by selecting, mentoring and accelerating the best high-impact entrepreneurs around the […]

October 2013

From Technology Networks Mass Spectrometry newsletter (link)

Analysis from Frost & Sullivan finds double-digit growth in Asia-Pacific and emerging markets to offset stagnation in US and Europe.

The global mass spectrometry (MS) market is growing much faster than the high-end analytical instrumentation market. This is a sign that demand is high in this technologically-dynamic market with broad applications and diversified end-user bases despite limited capital budgets in academia and the economic […]

October 2013

Indi (Integrated Diagnostics), a company based in Seattle, USA, announced XPRESYS™ a novel  lung blood test based on protein biomarker analysis with LC-MS technology with potential to help physicians identify more lung cancer nodules as likely benign and more patients as candidates for active surveillance instead of invasive procedures. Using innovative strategy, test does not seek to identify lung cancer; it is ONLY intended to assist physicians identify lung […]

September 2013

Distinguished MIT Professor Greg Stephanopoulos visited Fasmatech R&D facility on 17th of September 2013. Prof. Stephanopoulos was in Athens to address the opening event of the new Greek Chapter of the MIT Enterprise Forum (of which Dr. Emmanuel Raptakis of Fasmatech is a founding member). Prof. Stephanopoulos visited our laboratories, where he was brought up to date with our latest research results and product development activities.

Prof. Stephanopoulos is the […]

August 2013

Another important milestone is met for the advancement of mass spectrometry in the clinical diagnostics market.  VITEK® MS is the first MALDI MS clinical platform to receive a denovo FDA 510(k) clearance. This paves the way for further expansion of mass spectrometric technology in clinical diagnostics.

The Fasmatech team has a close connection to the introduction of MALDI MS in microbial ID. Dr. Raptakis, Fasmatech CEO,  through his various roles […]